60 results
8-K
EX-99.1
CTLT
Catalent, Inc.
29 Aug 24
Catalent, Inc. Reports Fourth Quarter and Fiscal 2024 Results
7:47am
, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi
8-K
EX-99.1
CTLT
Catalent, Inc.
29 May 24
Catalent Stockholders Approve Transaction with Novo Holdings
5:15pm
. is a global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply
8-K
EX-99.1
CTLT
Catalent, Inc.
8 May 24
Catalent, Inc. Reports Third Quarter Fiscal 2024 Results
4:20pm
, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad
DEFM14A
0msaemqte1m370ppi
15 Apr 24
Proxy related to merger
7:35am
PREM14A
uy1z8jam tm
3 Apr 24
Preliminary proxy related to merger
4:31pm
8-K
EX-99.1
jtfys qs5
9 Feb 24
Catalent, Inc. Reports Second Quarter Fiscal 2024 Results
8:04am
DEFA14A
e92 el1tzpdh
5 Feb 24
Additional proxy soliciting materials
7:03am
8-K
EX-99.1
i8ows xzw
5 Feb 24
Novo Holdings to Acquire Catalent
7:00am
8-K
EX-99.1
na4f5pimmruz3zez51a
19 Dec 23
Catalent Announces Closing of Incremental Term Loans
4:22pm
8-K
EX-99.1
adcn0joeide18p
15 Dec 23
Other Events
9:01am
8-K
EX-99.1
uchje4jdymgb 4tl
15 Nov 23
Catalent, Inc. Reports Preliminary First Quarter Fiscal 2024 Results and Reaffirms Full-Year Fiscal 2024 Guidance
7:05am
8-K
EX-99.1
6p0 3z1leqso
15 Sep 23
Catalent Receives NYSE Notice Regarding Late Form 10-K Filing
7:05am
DEFA14A
0d2rzns5aibrm21gw0a
29 Aug 23
Additional proxy soliciting materials
7:27am
8-K
EX-99.1
ej42udk4
29 Aug 23
Catalent Announces Governance Enhancements and New Initiatives to Drive Value
7:24am
8-K
EX-99.1
rkgnrdhnkj7d9smghsh
29 Aug 23
Catalent, Inc. Reports Preliminary Fourth Quarter and Fiscal 2023 Results
7:07am